Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prokidney (PROK) Change in Accured Expenses (2022 - 2025)

Historic Change in Accured Expenses for Prokidney (PROK) over the last 4 years, with Q3 2025 value amounting to $51000.0.

  • Prokidney's Change in Accured Expenses fell 9910.9% to $51000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.6 million, marking a year-over-year decrease of 319.91%. This contributed to the annual value of $11.6 million for FY2024, which is 40.38% down from last year.
  • Prokidney's Change in Accured Expenses amounted to $51000.0 in Q3 2025, which was down 9910.9% from -$2.2 million recorded in Q2 2025.
  • Prokidney's 5-year Change in Accured Expenses high stood at $13.0 million for Q2 2023, and its period low was -$5.9 million during Q1 2024.
  • Its 4-year average for Change in Accured Expenses is $1.0 million, with a median of $104000.0 in 2024.
  • Per our database at Business Quant, Prokidney's Change in Accured Expenses surged by 73908.78% in 2023 and then tumbled by 223846.15% in 2025.
  • Quarter analysis of 4 years shows Prokidney's Change in Accured Expenses stood at $533000.0 in 2022, then skyrocketed by 625.14% to $3.9 million in 2023, then soared by 202.87% to $11.7 million in 2024, then tumbled by 99.56% to $51000.0 in 2025.
  • Its Change in Accured Expenses was $51000.0 in Q3 2025, compared to -$2.2 million in Q2 2025 and -$5.9 million in Q1 2025.